Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Oral Ivermectin in Scabies Infected Children Weighing 5 to <15 kg
NCT04332068Phase 2Completed
- Sponsor
- University of Oxford
- Start
- Nov 2023
- Primary completion
- Apr 2025
- Modality
- Small Molecules
- Countries
- 3
01
Overview
A Phase 2 trial of CHILD-IVITAB in scabies, sponsored by University of Oxford. Started Nov 2023; status: completed.
02
Drugs
CHILD-IVITAB
03
Conditions
scabies
Beyond the preview
Go deeper on NCT04332068.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04332068.